Acadia Pharmaceuticals Stock Market Value
| ACAD Stock | USD 22.95 0.92 4.18% |
| Symbol | ACADIA |
Will Biotechnology sector continue expanding? Could ACADIA diversify its offerings? Factors like these will boost the valuation of ACADIA Pharmaceuticals. If investors know ACADIA will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every ACADIA Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 1.128 | Earnings Share 1.62 | Revenue Per Share | Quarterly Revenue Growth 0.113 | Return On Assets |
The market value of ACADIA Pharmaceuticals is measured differently than its book value, which is the value of ACADIA that is recorded on the company's balance sheet. Investors also form their own opinion of ACADIA Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is ACADIA Pharmaceuticals' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because ACADIA Pharmaceuticals' market value can be influenced by many factors that don't directly affect ACADIA Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that ACADIA Pharmaceuticals' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether ACADIA Pharmaceuticals represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, ACADIA Pharmaceuticals' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
ACADIA Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ACADIA Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ACADIA Pharmaceuticals.
| 11/20/2025 |
| 02/18/2026 |
If you would invest 0.00 in ACADIA Pharmaceuticals on November 20, 2025 and sell it all today you would earn a total of 0.00 from holding ACADIA Pharmaceuticals or generate 0.0% return on investment in ACADIA Pharmaceuticals over 90 days. ACADIA Pharmaceuticals is related to or competes with ADMA Biologics, Praxis Precision, Ligand Pharmaceuticals, Belite Bio, Soleno Therapeutics, Mirum Pharmaceuticals, and Crinetics Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small mole... More
ACADIA Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ACADIA Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ACADIA Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 9.22 | |||
| Value At Risk | (2.94) | |||
| Potential Upside | 3.31 |
ACADIA Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ACADIA Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ACADIA Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use ACADIA Pharmaceuticals historical prices to predict the future ACADIA Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.15) | |||
| Treynor Ratio | (0.04) |
ACADIA Pharmaceuticals February 18, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.03) | |||
| Mean Deviation | 1.67 | |||
| Coefficient Of Variation | (6,800) | |||
| Standard Deviation | 2.03 | |||
| Variance | 4.1 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.15) | |||
| Treynor Ratio | (0.04) | |||
| Maximum Drawdown | 9.22 | |||
| Value At Risk | (2.94) | |||
| Potential Upside | 3.31 | |||
| Skewness | 0.0174 | |||
| Kurtosis | (0.47) |
ACADIA Pharmaceuticals Backtested Returns
At this point, ACADIA Pharmaceuticals is very steady. ACADIA Pharmaceuticals retains Efficiency (Sharpe Ratio) of 0.0119, which signifies that the company had a 0.0119 % return per unit of risk over the last 3 months. We have found twenty-two technical indicators for ACADIA Pharmaceuticals, which you can use to evaluate the volatility of the entity. Please confirm ACADIA Pharmaceuticals' market risk adjusted performance of (0.03), and Variance of 4.1 to double-check if the risk estimate we provide is consistent with the expected return of 0.0246%. The firm owns a Beta (Systematic Risk) of 0.96, which signifies possible diversification benefits within a given portfolio. ACADIA Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, ACADIA Pharmaceuticals is expected to follow. ACADIA Pharmaceuticals at this moment owns a risk of 2.06%. Please confirm ACADIA Pharmaceuticals mean deviation, jensen alpha, potential upside, as well as the relationship between the standard deviation and treynor ratio , to decide if ACADIA Pharmaceuticals will be following its current price history.
Auto-correlation | -0.47 |
Modest reverse predictability
ACADIA Pharmaceuticals has modest reverse predictability. Overlapping area represents the amount of predictability between ACADIA Pharmaceuticals time series from 20th of November 2025 to 4th of January 2026 and 4th of January 2026 to 18th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ACADIA Pharmaceuticals price movement. The serial correlation of -0.47 indicates that about 47.0% of current ACADIA Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.47 | |
| Spearman Rank Test | -0.68 | |
| Residual Average | 0.0 | |
| Price Variance | 3.05 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether ACADIA Pharmaceuticals is a strong investment it is important to analyze ACADIA Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ACADIA Pharmaceuticals' future performance. For an informed investment choice regarding ACADIA Stock, refer to the following important reports:Check out ACADIA Pharmaceuticals Correlation, ACADIA Pharmaceuticals Volatility and ACADIA Pharmaceuticals Performance module to complement your research on ACADIA Pharmaceuticals. For information on how to trade ACADIA Stock refer to our How to Trade ACADIA Stock guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
ACADIA Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.